Status:

COMPLETED

Consumption of Chocolate in Pregnant Women.

Lead Sponsor:

Laval University

Conditions:

Preeclampsia

Eligibility:

FEMALE

18-40 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to investigate the acute and chronic effect of consumption of flavanol-rich chocolate on endothelium function in pregnant women at high risk for preeclampsia.

Detailed Description

Although numerous strategies have been studied, no effective prevention or treatment of preeclampsia is yet available for pregnant women. This is surprising considering the growing body of literature ...

Eligibility Criteria

Inclusion

  • Pregnant women between the ages of 18 and 40 years.
  • Presence of uterine diastolic notches measured by uterine artery Doppler between 10 and 14 weeks.

Exclusion

  • Hypertension requiring medication.
  • Currently or previously use of medications interfering with glucose or lipids metabolism.
  • Use of supplements or natural health products that interfere with blood pressure.
  • Consumption of 1 or more alcohol drink per day.
  • Allergy or intolerance to nuts or chocolate.

Key Trial Info

Start Date :

May 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2014

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT01431443

Start Date

May 1 2011

End Date

September 1 2014

Last Update

April 9 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Laval University, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels.

Québec, Quebec, Canada, G1V 0A6